Furthermore, ECs enhance EMT, breast cancer cell migration, invasion and metastasis by the release of the plasminogen activator inhibitor-1 (PAI-1) and the chemokine CCL5 [26]. The gene discussed is SERPINE1; the disease is breast carcinoma.